Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hinge Health (HNGE) Cash & Current Investments (2023 - 2025)

Hinge Health (HNGE) has disclosed Cash & Current Investments for 3 consecutive years, with $363.9 million as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments fell 22.01% to $363.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $363.9 million through Dec 2025, down 22.01% year-over-year, with the annual reading at $363.9 million for FY2025, 22.01% down from the prior year.
  • Cash & Current Investments hit $363.9 million in Q4 2025 for Hinge Health, down from $480.0 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $480.0 million in Q3 2025 to a low of $235.0 million in Q4 2023.
  • Historically, Cash & Current Investments has averaged $351.8 million across 3 years, with a median of $363.9 million in 2025.
  • Biggest five-year swings in Cash & Current Investments: soared 98.58% in 2024 and later dropped 22.01% in 2025.
  • Year by year, Cash & Current Investments stood at $235.0 million in 2023, then surged by 98.58% to $466.6 million in 2024, then decreased by 22.01% to $363.9 million in 2025.
  • Business Quant data shows Cash & Current Investments for HNGE at $363.9 million in Q4 2025, $480.0 million in Q3 2025, and $413.3 million in Q2 2025.